HealthMyne, Inc.
MADISON, WI · Founded 2013 · CIK 0001636091 · Medtech · Private
Integrated clinical and imaging data analytics platform for oncology that combines patient records, radiology images, and AI-driven image segmentation, registration, and lesion comparison to support c
healthmyne.com →- Grants
- $1.2M
- 1 award
- Sector median: 1
- Raised
- $19M
- 2 Form D · Aug 2018
- 97 months since last filing
- Contracts
- $225K
- 1 award · Health and Human S
- #447 of 4531 in medtech
- Patents
- 7
- 3 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: A Minable, Quantitative Imaging Platform for Evidence-Based Medicine within Oncology | $1,176,541 | |
| Private capital raised | Form D · SEC | $4,485,000 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Topic 380 - Qids: Using Radiomics To Impact Radiotherapy Treatment Planning - Moonshot | $225,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 444 | Maximum Fidelity Surgical Simulations, Inc. | $228K | $2.2M |
| 445 | ASURAGEN, INC. | $227K | $13M |
| 446 | WINDTREE THERAPEUTICS, INC. | $225K | — |
| 447 | HealthMyne, Inc. | $225K | $19M |
| 448 | DETON CORP | $225K | — |
| 449 | NANOHYBRIDS INC | $225K | — |
| 450 | XILIS INC | $225K | $109M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Scott ButtonDirector
- Roger ChyllaDirector · Executive Officer
- John KuelperDirector
- T. MackieDirector
- Thomas MackieDirector
- Dan MalvenDirector
- Linda PeitzmanExecutive Officer
- Greg RobinsonDirector
- Milton Silva-CraigDirector
- Praveen SinhaDirector · Executive Officer
- Arvind SubramanianDirector · Executive Officer
- Hao WangExecutive Officer
Patents
- Systems And Methods For Volumetric Segmentation Of Structures In Planar Medical Imagesgranted
- Systems And Methods For Semi-automatic Tumor Segmentationgranted
- Systems And Methods For Volumetric Segmentation Of Structures In Planar Medical Imagesgranted
- Systems And Methods For Analyzing Medical Imagesapplication
- Systems And Methods For Semi-automatic Brain Tumor Segmentationapplication
- Systems And Methods For Semi-automatic Tumor Segmentationapplication
- Systems And Methods For Volumetric Segmentation Of Structures In Planar Medical Imagesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.